|
|
Blood, 15 October 2008, Vol. 112, No. 8, pp. 3227-3233.
Prepublished online as a Blood First Edition Paper on July 8, 2008; DOI 10.1182/blood-2008-02-139113.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
The glycoprotein Ib-IX-V complex contributes to tissue factor–independent thrombin generation by recombinant factor VIIa on the activated platelet surface
Cees Weeterings1,2,
Philip G. de Groot1,2,
Jelle Adelmeijer3, and
Ton Lisman13
1 Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht;
2 Institute of Biomembranes, Utrecht University, Utrecht; and
3 Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Several lines of evidence suggest that recombinant factor VIIa (rFVIIa) is able to activate factor X on an activated platelet, in a tissue factor-independent manner. We hypothesized that, besides the anionic surface, a receptor on the activated platelet surface is involved in this process. Here, we showed that, in an ELISA setup, a purified extracellular fragment of GPIb bound to immobilized rFVIIa. Surface plasmon resonance established a affinity constant (Kd) of approximately 20 nM for this interaction. In addition, CHO cells transfected with the GPIb-IX-V complex could adhere to immobilized rFVIIa, whereas wild-type CHO cells could not. Furthermore, platelets sti-mulated with a combination of collagen and thrombin adhered to immobilized rFVIIa under static conditions. Platelet adhesion was inhibited by treatment with O-sialoglycoprotein endopeptidase, which specifically cleaves GPIb from the platelet surface. In addition, rFVIIa-mediated thrombin generation on the activated platelet surface was inhibited by cleaving GPIb from its surface. In summary, 3 lines of evidence showed that rFVIIa interacts with the GPIb-IX-V complex, and this interaction enhanced tissue factor-independent thrombin generation mediated by rFVIIa on the activated platelet surface. The rFVIIa-GPIb interaction could contribute to cessation of bleeding after administration of rFVIIa to patients with bleeding disorders.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
FVIIa: you've come a long way, baby!
- Maureane Hoffman
Blood 2008 112: 3002-3003.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
T. Lisman
Factor XI Binding to Platelets: Glycoprotein Ib{alpha} Has an Accomplice
Arterioscler Thromb Vasc Biol,
October 1, 2009;
29(10):
1409 - 1410.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Guyot, A. Carillion, M.-L. Poli-Merol, I. Ferrand, C. Amory, D. Chaoudi, S. Poret, and J.-M. Malinovsky
Ehlers-Danlos syndrome type IV in a child admitted in emergency with peritonitis
Br. J. Anaesth.,
October 1, 2009;
103(4):
615 - 616.
[Full Text]
[PDF]
|
 |
|
|
|